Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1993 Apr;69(2):112–114. doi: 10.1136/sti.69.2.112

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

D J White 1, E M Johnson 1, D W Warnock 1
PMCID: PMC1195041  PMID: 8389723

Abstract

CASE REPORT--SUBJECTS--Three cases are described of long-standing vaginal candidosis due to Candida glabrata. These had failed to respond to local and systemic antifungals. In each case the infecting strain appeared resistant to a range of azole drugs in vitro. CLINICAL COURSE--Case one--This patient recovered following prolonged treatment with oral itraconazole in combination with oral and vaginal nystatin. Case two. Yeasts were eradicated from this patient following cyclical treatment with oral dydrogesterone; prolonged vaginal treatment with nystatin may have helped. Case three. This patient did not respond to a prolonged course of oral itraconazole in combination with vaginal and oral nystatin, oral medroxyprogesterone or intravaginal boric acid. Eradication of C glabrata was finally achieved by local application of 1% gentian violet. Shortly after eradication of the C glabrata infection, both Case two and Case three developed infections with other Candida species responsive to azole antifungals.

Full text

PDF
112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dennerstein G. J. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med. 1986 Sep;31(9):801–803. [PubMed] [Google Scholar]
  2. Kerridge D., Nicholas R. O. Drug resistance in the opportunistic pathogens Candida albicans and Candida glabrata. J Antimicrob Chemother. 1986 Oct;18 (Suppl B):39–49. doi: 10.1093/jac/18.supplement_b.39. [DOI] [PubMed] [Google Scholar]
  3. Oriel J. D., Partridge B. M., Denny M. J., Coleman J. C. Genital yeast infections. Br Med J. 1972 Dec 30;4(5843):761–764. doi: 10.1136/bmj.4.5843.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Redondo-Lopez V., Lynch M., Schmitt C., Cook R., Sobel J. D. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol. 1990 Oct;76(4):651–655. [PubMed] [Google Scholar]
  5. Warnock D. W., Burke J., Cope N. J., Johnson E. M., von Fraunhofer N. A., Williams E. W. Fluconazole resistance in Candida glabrata. Lancet. 1988 Dec 3;2(8623):1310–1310. doi: 10.1016/s0140-6736(88)92919-4. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES